GB0011071D0 - Organic compounds - Google Patents
Organic compoundsInfo
- Publication number
- GB0011071D0 GB0011071D0 GBGB0011071.8A GB0011071A GB0011071D0 GB 0011071 D0 GB0011071 D0 GB 0011071D0 GB 0011071 A GB0011071 A GB 0011071A GB 0011071 D0 GB0011071 D0 GB 0011071D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- sub
- organic compounds
- formula
- compounds
- pharmaceuticals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108050001286 Somatostatin Receptor Proteins 0.000 abstract 1
- 102000011096 Somatostatin receptor Human genes 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0011071.8A GB0011071D0 (en) | 2000-05-08 | 2000-05-08 | Organic compounds |
| ES01940412T ES2330305T3 (es) | 2000-05-08 | 2001-05-07 | Derivados de hidantoina con afinidad por los receptores de la somatostatina. |
| AU73998/01A AU7399801A (en) | 2000-05-08 | 2001-05-07 | Hydantoin derivatives with affinity for somatostatin receptors |
| EP01940412A EP1282617B1 (en) | 2000-05-08 | 2001-05-07 | Hydantoin derivatives with affinity for somatostatin receptors |
| DE60139770T DE60139770D1 (de) | 2000-05-08 | 2001-05-07 | Hydantoin derivate mit affinität für somatostatin rezeptoren |
| AT01940412T ATE441642T1 (de) | 2000-05-08 | 2001-05-07 | Hydantoin derivate mit affinität für somatostatin rezeptoren |
| CA002405968A CA2405968A1 (en) | 2000-05-08 | 2001-05-07 | Hydantoin derivatives with affinity for somatostatin receptors |
| US10/333,388 US7019004B2 (en) | 2000-05-08 | 2001-05-07 | Hydantoin derivatives with affinity for somatostatin receptors |
| PCT/EP2001/005162 WO2001085718A1 (en) | 2000-05-08 | 2001-05-07 | Hydantoin derivatives with affinity for somatostatin receptors |
| JP2001582319A JP2003532724A (ja) | 2000-05-08 | 2001-05-07 | ソマトスタチン誘導体に親和性を有する、ヒダントイン誘導体 |
| PT01940412T PT1282617E (pt) | 2000-05-08 | 2001-05-07 | Derivados de hidantoína com afinidade para os receptores da somatostatina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0011071.8A GB0011071D0 (en) | 2000-05-08 | 2000-05-08 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0011071D0 true GB0011071D0 (en) | 2000-06-28 |
Family
ID=9891182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0011071.8A Ceased GB0011071D0 (en) | 2000-05-08 | 2000-05-08 | Organic compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7019004B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1282617B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003532724A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE441642T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU7399801A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2405968A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60139770D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2330305T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0011071D0 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1282617E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001085718A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7232924B2 (en) | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US20040019092A1 (en) * | 2001-11-14 | 2004-01-29 | Daniel Berney | Non-peptide somatostatin receptor ligands |
| WO2003057214A1 (en) * | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| AU2004315596B2 (en) | 2003-08-29 | 2011-11-24 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis |
| WO2010075561A1 (en) | 2008-12-23 | 2010-07-01 | President And Fellows Of Harvard College | Small molecule inhibitors of necroptosis |
| WO2014145022A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| WO2016094846A1 (en) | 2014-12-11 | 2016-06-16 | President And Fellows Of Harvard College | Inhibitors of cellular necrosis and related methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859190A (en) * | 1997-02-04 | 1999-01-12 | Trega Biosciences, Inc. | Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein |
| FR2796945B1 (fr) | 1999-07-30 | 2002-06-28 | Sod Conseils Rech Applic | Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments |
| US20040019092A1 (en) * | 2001-11-14 | 2004-01-29 | Daniel Berney | Non-peptide somatostatin receptor ligands |
| WO2003057214A1 (en) * | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
-
2000
- 2000-05-08 GB GBGB0011071.8A patent/GB0011071D0/en not_active Ceased
-
2001
- 2001-05-07 DE DE60139770T patent/DE60139770D1/de not_active Expired - Fee Related
- 2001-05-07 CA CA002405968A patent/CA2405968A1/en not_active Abandoned
- 2001-05-07 AU AU73998/01A patent/AU7399801A/en not_active Abandoned
- 2001-05-07 PT PT01940412T patent/PT1282617E/pt unknown
- 2001-05-07 AT AT01940412T patent/ATE441642T1/de not_active IP Right Cessation
- 2001-05-07 ES ES01940412T patent/ES2330305T3/es not_active Expired - Lifetime
- 2001-05-07 JP JP2001582319A patent/JP2003532724A/ja active Pending
- 2001-05-07 EP EP01940412A patent/EP1282617B1/en not_active Expired - Lifetime
- 2001-05-07 US US10/333,388 patent/US7019004B2/en not_active Expired - Fee Related
- 2001-05-07 WO PCT/EP2001/005162 patent/WO2001085718A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE441642T1 (de) | 2009-09-15 |
| DE60139770D1 (de) | 2009-10-15 |
| EP1282617B1 (en) | 2009-09-02 |
| US20040110779A1 (en) | 2004-06-10 |
| PT1282617E (pt) | 2009-12-09 |
| EP1282617A1 (en) | 2003-02-12 |
| WO2001085718A1 (en) | 2001-11-15 |
| AU7399801A (en) | 2001-11-20 |
| US7019004B2 (en) | 2006-03-28 |
| ES2330305T3 (es) | 2009-12-09 |
| JP2003532724A (ja) | 2003-11-05 |
| CA2405968A1 (en) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY129613A (en) | Cannabinoid receptor binding compounds | |
| GB0128996D0 (en) | Organic compounds | |
| ATE270817T1 (de) | Fungizide | |
| WO2003016282A3 (en) | Substituted 1h-dihydropyrazoles, their preparation and use | |
| IL157773A0 (en) | 2-amino-propanol derivatives | |
| SE0004245D0 (sv) | Novel compounds and their use | |
| GB9929552D0 (en) | Compounds | |
| GB0127903D0 (en) | Improvements relating to organic compounds | |
| GB0114185D0 (en) | Compounds | |
| SE9702773D0 (sv) | Novel compounds | |
| MY133969A (en) | Indoloquinazolinones | |
| MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
| PT1282617E (pt) | Derivados de hidantoína com afinidade para os receptores da somatostatina | |
| BG105847A (en) | Calcilytic compounds | |
| DK1204659T3 (da) | Serotonerge benzofuraner | |
| EP1189909A4 (en) | NOVEL ALUMINOSILOXANE COMPOUNDS, AND PROCESS FOR THEIR PREPARATION | |
| DE60001366D1 (de) | Orale zusammensetzung enthaltend perlit | |
| WO2003042234A3 (en) | Non-peptide somatostatin receptor ligands | |
| ID27440A (id) | Proses untuk menyiapkan penengah-penengah | |
| DE60043228D1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
| ZA983231B (en) | Substituted benzyloxyimino compounds. | |
| IL159493A0 (en) | Pharmaceutical formulation containing an ltb4 antagonist | |
| GB0322750D0 (en) | Organic compounds | |
| MXPA03001440A (es) | Compuestos de trioxepano novedosos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |